{"pmid":32142972,"title":"Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.","text":["Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China.","Anaesth Crit Care Pain Med","Rello, Jordi","Tejada, Sofia","Userovici, Caroline","Arvaniti, Kostoula","Pugin, Jerome","Waterer, Grant","32142972"],"journal":"Anaesth Crit Care Pain Med","authors":["Rello, Jordi","Tejada, Sofia","Userovici, Caroline","Arvaniti, Kostoula","Pugin, Jerome","Waterer, Grant"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32142972","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.accpm.2020.03.001","keywords":["Coronavirus","Influenza","Intensive care medicine","Mechanical ventilation","Outbreak","Pneumonia","SARS-COV-2"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1661359647730171907,"score":6.7365713,"similar":[{"pmid":32040667,"title":"Critical care management of adults with community-acquired severe respiratory viral infection.","text":["Critical care management of adults with community-acquired severe respiratory viral infection.","With the expanding use of molecular assays, viral pathogens are increasingly recognized among critically ill adult patients with community-acquired severe respiratory illness; studies have detected respiratory viral infections (RVIs) in 17-53% of such patients. In addition, novel pathogens including zoonotic coronaviruses like the agents causing Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and the 2019 novel coronavirus (2019 nCoV) are still being identified. Patients with severe RVIs requiring ICU care present typically with hypoxemic respiratory failure. Oseltamivir is the most widely used neuraminidase inhibitor for treatment of influenza; data suggest that early use is associated with reduced mortality in critically ill patients with influenza. At present, there are no antiviral therapies of proven efficacy for other severe RVIs. Several adjunctive pharmacologic interventions have been studied for their immunomodulatory effects, including macrolides, corticosteroids, cyclooxygenase-2 inhibitors, sirolimus, statins, anti-influenza immune plasma, and vitamin C, but none is recommended at present in severe RVIs. Evidence-based supportive care is the mainstay for management of severe respiratory viral infection. Non-invasive ventilation in patients with severe RVI causing acute hypoxemic respiratory failure and pneumonia is associated with a high likelihood of transition to invasive ventilation. Limited existing knowledge highlights the need for data regarding supportive care and adjunctive pharmacologic therapy that is specific for critically ill patients with severe RVI. There is a need for more pragmatic and efficient designs to test different therapeutics both individually and in combination.","Intensive Care Med","Arabi, Yaseen M","Fowler, Robert","Hayden, Frederick G","32040667"],"abstract":["With the expanding use of molecular assays, viral pathogens are increasingly recognized among critically ill adult patients with community-acquired severe respiratory illness; studies have detected respiratory viral infections (RVIs) in 17-53% of such patients. In addition, novel pathogens including zoonotic coronaviruses like the agents causing Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and the 2019 novel coronavirus (2019 nCoV) are still being identified. Patients with severe RVIs requiring ICU care present typically with hypoxemic respiratory failure. Oseltamivir is the most widely used neuraminidase inhibitor for treatment of influenza; data suggest that early use is associated with reduced mortality in critically ill patients with influenza. At present, there are no antiviral therapies of proven efficacy for other severe RVIs. Several adjunctive pharmacologic interventions have been studied for their immunomodulatory effects, including macrolides, corticosteroids, cyclooxygenase-2 inhibitors, sirolimus, statins, anti-influenza immune plasma, and vitamin C, but none is recommended at present in severe RVIs. Evidence-based supportive care is the mainstay for management of severe respiratory viral infection. Non-invasive ventilation in patients with severe RVI causing acute hypoxemic respiratory failure and pneumonia is associated with a high likelihood of transition to invasive ventilation. Limited existing knowledge highlights the need for data regarding supportive care and adjunctive pharmacologic therapy that is specific for critically ill patients with severe RVI. There is a need for more pragmatic and efficient designs to test different therapeutics both individually and in combination."],"journal":"Intensive Care Med","authors":["Arabi, Yaseen M","Fowler, Robert","Hayden, Frederick G"],"date":"2020-02-11T11:00:00Z","year":2020,"_id":"32040667","week":"20207|Feb 10 - Feb 16","doi":"10.1007/s00134-020-05943-5","keywords":["Acute respiratory distress syndrome","Antiviral therapy","Coronavirus","Influenza","Neuraminidase inhibitor"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661359647215321089,"score":64.28065},{"pmid":32088344,"title":"COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics.","text":["COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics.","Anaesth Crit Care Pain Med","Ling, Lowell","Joynt, Gavin M","Lipman, Jeff","Constantin, Jean-Michel","Joannes-Boyau, Olivier","32088344"],"journal":"Anaesth Crit Care Pain Med","authors":["Ling, Lowell","Joynt, Gavin M","Lipman, Jeff","Constantin, Jean-Michel","Joannes-Boyau, Olivier"],"date":"2020-02-24T11:00:00Z","year":2020,"_id":"32088344","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.accpm.2020.02.002","keywords":["Infection control","Outbreak","SARS-CoV-2"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661359647411404800,"score":57.0822},{"pmid":31985790,"title":"Potential for global spread of a novel coronavirus from China.","text":["Potential for global spread of a novel coronavirus from China.","J Travel Med","Bogoch, Isaac I","Watts, Alexander","Thomas-Bachli, Andrea","Huber, Carmen","Kraemer, Moritz U G","Khan, Kamran","31985790"],"journal":"J Travel Med","authors":["Bogoch, Isaac I","Watts, Alexander","Thomas-Bachli, Andrea","Huber, Carmen","Kraemer, Moritz U G","Khan, Kamran"],"date":"2020-01-28T11:00:00Z","year":2020,"_id":"31985790","week":"20205|Jan 27 - Feb 02","doi":"10.1093/jtm/taaa011","keywords":["Coronavirus","Outbreak","Pneumonia","SARS","Travel","Wuhan","Zoonosis"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1661359647178620928,"score":49.3072},{"pmid":31943059,"title":"Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel.","text":["Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel.","There is currently an outbreak of a pneumonia of unknown etiology in Wuhan, China. While there are still several unanswered questions, we evaluate the potential for international dissemination of this disease via commercial air travel should the outbreak continue.","J Travel Med","Bogoch, Isaac I","Watts, Alexander","Thomas-Bachli, Andrea","Huber, Carmen","Kraemer, Moritz U G","Khan, Kamran","31943059"],"abstract":["There is currently an outbreak of a pneumonia of unknown etiology in Wuhan, China. While there are still several unanswered questions, we evaluate the potential for international dissemination of this disease via commercial air travel should the outbreak continue."],"journal":"J Travel Med","authors":["Bogoch, Isaac I","Watts, Alexander","Thomas-Bachli, Andrea","Huber, Carmen","Kraemer, Moritz U G","Khan, Kamran"],"date":"2020-01-17T11:00:00Z","year":2020,"_id":"31943059","week":"20203|Jan 13 - Jan 19","doi":"10.1093/jtm/taaa008","keywords":["Air Travel","Coronavirus","Outbreak","Pneumonia","SARS","Zoonosis"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["General Info"],"weight":1,"_version_":1661359647184912384,"score":47.758442},{"pmid":32087621,"title":"[The keypoints in treatment of the critical novel coronavirus pneumonia patient].","text":["[The keypoints in treatment of the critical novel coronavirus pneumonia patient].","The novel coronavirus pneumonia (new coronavirus pneumonia) (NCP) has been prevalent in Wuhan and spread rapidly to all of our country. Some cases can develop into ARDS, or even death. We will share the treatment experience of severe NCP with the first-line treatment experience. The best respiratory support mode should be selected, but the timing of intubation and protection during intubation are two difficulties; patients with high level peep and poor effect in prone position can be given ECMO support. For NCP patients with mechanical ventilation, reasonable sedation and analgesia strategies should be formulated; delirium should not be ignored. In addition, there is up regulation of inflammatory factors in patients with severe NCP, but the effect of renal replacement therapy needs to be further confirmed by clinical research.","Zhonghua Jie He He Hu Xi Za Zhi","Qiu, H B","Li, X Y","Du, B","Kang, H Y J","Wang, Y S","Wang, F","Sun, B","Tong, Z H","32087621"],"abstract":["The novel coronavirus pneumonia (new coronavirus pneumonia) (NCP) has been prevalent in Wuhan and spread rapidly to all of our country. Some cases can develop into ARDS, or even death. We will share the treatment experience of severe NCP with the first-line treatment experience. The best respiratory support mode should be selected, but the timing of intubation and protection during intubation are two difficulties; patients with high level peep and poor effect in prone position can be given ECMO support. For NCP patients with mechanical ventilation, reasonable sedation and analgesia strategies should be formulated; delirium should not be ignored. In addition, there is up regulation of inflammatory factors in patients with severe NCP, but the effect of renal replacement therapy needs to be further confirmed by clinical research."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Qiu, H B","Li, X Y","Du, B","Kang, H Y J","Wang, Y S","Wang, F","Sun, B","Tong, Z H"],"date":"2020-02-24T11:00:00Z","year":2020,"_id":"32087621","week":"20209|Feb 24 - Mar 01","doi":"10.3760/cma.j.cn112147-20200222-00151","keywords":["Acute respiratory distress syndrome (ARDS)","Delirium","Mechanical ventilation","Novel coronavirus pneumonia (NCP)","Renal replacement therapy","Sedation and analgesia"],"source":"PubMed","locations":["analgesia","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1661359647410356225,"score":46.939842}]}